5 Biotech Stocks We Like in 2026. And 5 We Don't
Our disruptive technology investing methodology is an excellent way to help investors avoid garbage companies. Today, we'll talk about five biotech stocks we correctly called out as rubbish: Vicarious Surgical $RBOT, Bionano Genomics $BNGO, Renalytix $RNLXY, Lantern Pharma $LTRN, and CollPlant $CLGN, and five biotechs we like: Intuitive Surgical $ISRG, Tempus AI $TEM, TransMedics $TMDX, Recursion $RXRX, and United Therapeutics $UTHR.Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.